Immune-driven remodeling in calcific aortic valve disease: mechanisms and immunotherapeutic opportunities
- 1Institute of Intelligent Sport and Proactive Health, Department of Health and Physical Education, Jianghan University
Abstract
Calcific aortic valve disease (CAVD) is a prevalent degenerative valvular disorder in the aging population, for which no pharmacological therapy has proven effective in halting or reversing disease progression. Over the past decade, CAVD has been increasingly recognized not as a passive degenerative process of calcium deposition, but as an active, inflammation-driven disease characterized by osteogenic remodeling. This process is initiated and sustained by endothelial injury, lipid retention, immune cell infiltration, and phenotypic transition of valvular interstitial cells. Growing evidence indicates that innate and adaptive immune responses may contribute to disease amplification. Innate immune cells propagate local inflammatory signaling through inflammasome activation, extracellular vesicle communication, protease release, and neutrophil extracellular trap formation, while adaptive immune cells further shape disease progression by sustaining cytokine networks that promote fibrosis and osteogenic reprogramming within the valvular microenvironment. Based on these mechanistic insights, this review further discusses emerging translational strategies aimed at targeting key pathogenic processes in CAVD, including modulation of inflammatory signaling, restoration of adaptive immune homeostasis, regulation of extracellular matrix remodeling and antifibrotic pathways, inhibition of VIC osteogenic differentiation, as well as development of patient stratification and local drug delivery approaches. Collectively, these strategies may provide a conceptual framework for earlier, non-surgical interventions for CAVD.
Related
- Immune remodeling in inflammatory bowel disease-associated colorectal cancer: Mechanisms and immunotherapeutic implications (Review)
- Chronic Inflammation, Fibrotic Remodeling, and Regenerative Failure in Duchenne Muscular Dystrophy: Mechanisms and Therapeutic Opportunities
- Neuroimmune crosstalk in cancer: emerging immunotherapeutic opportunities.
- Ultrasound-induced immunogenic cell death in cancer: mechanisms, immune remodeling, and therapeutic opportunities
- Metabolic Dysfunction and T-Cell Exhaustion in Colorectal Cancer: Mechanisms, Microenvironment Remodeling, and Therapeutic Opportunities
BibTeX
@article{zhang2026immunedriven,
title = {{Immune-driven remodeling in calcific aortic valve disease: mechanisms and immunotherapeutic opportunities}},
author = {Xi Zhang and Yi Si and Ling Liao and Yuxiang Wu},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1906690},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1906690/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Immune-driven remodeling in calcific aortic valve disease: mechanisms and immunotherapeutic opportunities
AU - Xi Zhang
AU - Yi Si
AU - Ling Liao
AU - Yuxiang Wu
PY - 2026
DA - 2026/10/19
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1906690
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1906690/full
AB - Calcific aortic valve disease (CAVD) is a prevalent degenerative valvular disorder in the aging population, for which no pharmacological therapy has proven effective in halting or reversing disease progression. Over the past decade, CAVD has been increasingly recognized not as a passive degenerative process of calcium deposition, but as an active, inflammation-driven disease characterized by osteogenic remodeling. This process is initiated and sustained by endothelial injury, lipid retention, immune cell infiltration, and phenotypic transition of valvular interstitial cells. Growing evidence indicates that innate and adaptive immune responses may contribute to disease amplification. Innate immune cells propagate local inflammatory signaling through inflammasome activation, extracellular vesicle communication, protease release, and neutrophil extracellular trap formation, while adaptive immune cells further shape disease progression by sustaining cytokine networks that promote fibrosis and osteogenic reprogramming within the valvular microenvironment. Based on these mechanistic insights, this review further discusses emerging translational strategies aimed at targeting key pathogenic processes in CAVD, including modulation of inflammatory signaling, restoration of adaptive immune homeostasis, regulation of extracellular matrix remodeling and antifibrotic pathways, inhibition of VIC osteogenic differentiation, as well as development of patient stratification and local drug delivery approaches. Collectively, these strategies may provide a conceptual framework for earlier, non-surgical interventions for CAVD.
SN - 1664-3224
ER -